JP2022524576A5 - - Google Patents
Info
- Publication number
- JP2022524576A5 JP2022524576A5 JP2021545837A JP2021545837A JP2022524576A5 JP 2022524576 A5 JP2022524576 A5 JP 2022524576A5 JP 2021545837 A JP2021545837 A JP 2021545837A JP 2021545837 A JP2021545837 A JP 2021545837A JP 2022524576 A5 JP2022524576 A5 JP 2022524576A5
- Authority
- JP
- Japan
- Prior art keywords
- subjects
- approximately
- blood pressure
- subject
- ambulatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025018962A JP2025084777A (ja) | 2019-03-18 | 2025-02-07 | 過活動膀胱を処置するためのビベグロンの使用 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962820230P | 2019-03-18 | 2019-03-18 | |
| US62/820,230 | 2019-03-18 | ||
| US201962830302P | 2019-04-05 | 2019-04-05 | |
| US62/830,302 | 2019-04-05 | ||
| US201962842435P | 2019-05-02 | 2019-05-02 | |
| US62/842,435 | 2019-05-02 | ||
| US201962885767P | 2019-08-12 | 2019-08-12 | |
| US62/885,767 | 2019-08-12 | ||
| US201962897019P | 2019-09-06 | 2019-09-06 | |
| US62/897,019 | 2019-09-06 | ||
| US201962904429P | 2019-09-23 | 2019-09-23 | |
| US62/904,429 | 2019-09-23 | ||
| PCT/IB2020/052484 WO2020188505A1 (en) | 2019-03-18 | 2020-03-18 | Use of vibegron to treat overactive bladder |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018962A Division JP2025084777A (ja) | 2019-03-18 | 2025-02-07 | 過活動膀胱を処置するためのビベグロンの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022524576A JP2022524576A (ja) | 2022-05-09 |
| JP2022524576A5 true JP2022524576A5 (https=) | 2023-04-03 |
Family
ID=70166082
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545837A Pending JP2022524576A (ja) | 2019-03-18 | 2020-03-18 | 過活動膀胱を処置するためのビベグロンの使用 |
| JP2025018962A Pending JP2025084777A (ja) | 2019-03-18 | 2025-02-07 | 過活動膀胱を処置するためのビベグロンの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025018962A Pending JP2025084777A (ja) | 2019-03-18 | 2025-02-07 | 過活動膀胱を処置するためのビベグロンの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230027066A1 (https=) |
| EP (1) | EP3941473A1 (https=) |
| JP (2) | JP2022524576A (https=) |
| KR (2) | KR20210142004A (https=) |
| CN (2) | CN121489955A (https=) |
| AU (2) | AU2020243514A1 (https=) |
| BR (1) | BR112021017198A2 (https=) |
| CA (1) | CA3129024A1 (https=) |
| IL (1) | IL285910A (https=) |
| MX (1) | MX2021009488A (https=) |
| PH (1) | PH12021551975A1 (https=) |
| SG (1) | SG11202108810YA (https=) |
| TW (2) | TW202102221A (https=) |
| WO (1) | WO2020188505A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3634420A1 (en) | 2017-06-06 | 2020-04-15 | Urovant Sciences GmbH | Use of vibegron to treat overactive bladder |
| SG11202103662VA (en) | 2018-12-05 | 2021-06-29 | Urovant Sciences Gmbh | Vibegron for the treatment of overactive bladder symptoms |
| TW202245781A (zh) * | 2021-02-16 | 2022-12-01 | 瑞士商優洛凡特科學公司 | 用維貝格龍（ｖｉｂｅｇｒｏｎ）治療心臟衰竭之方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20091825A1 (es) | 2008-04-04 | 2009-12-04 | Merck & Co Inc | Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3 |
| ES2584427T3 (es) | 2011-10-27 | 2016-09-27 | Merck Sharp & Dohme Corp. | Proceso para la preparación de agonistas beta 3 y productos intermedios |
| WO2013062881A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Process for making beta 3 agonists and intermediates |
| RS59402B1 (sr) | 2013-03-15 | 2019-11-29 | Merck Sharp & Dohme | Postupak za pripremu beta 3 agonista i međuproizvoda |
| JP6197971B1 (ja) * | 2016-04-22 | 2017-09-20 | 小野薬品工業株式会社 | Ｋｃｎｑ２〜５チャネル関連疾患の予防および／または治療剤 |
| US20170348288A1 (en) * | 2016-06-03 | 2017-12-07 | Velicept Therapeutics, Inc. | Dosing regimens for beta-3 adrenoceptor agonists and anti-muscarinic agents for the treatment and prevention of lower urinary tract symptoms and overactive bladder |
| US10057209B2 (en) * | 2016-07-28 | 2018-08-21 | Qualcomm Incorporated | Time-sequenced multi-device address assignment |
| JP7670461B2 (ja) * | 2017-06-06 | 2025-04-30 | ウロバント サイエンシズ ゲゼルシャフト ミット ベシュレンクター ハフトゥング | 過活動膀胱の治療のためのビベグロンの投薬 |
| EP3634420A1 (en) * | 2017-06-06 | 2020-04-15 | Urovant Sciences GmbH | Use of vibegron to treat overactive bladder |
| EP3583905A1 (en) * | 2018-06-20 | 2019-12-25 | Arthrex Inc | Percutaneous targeting device |
-
2020
- 2020-03-18 JP JP2021545837A patent/JP2022524576A/ja active Pending
- 2020-03-18 US US17/440,612 patent/US20230027066A1/en active Pending
- 2020-03-18 SG SG11202108810Y patent/SG11202108810YA/en unknown
- 2020-03-18 MX MX2021009488A patent/MX2021009488A/es unknown
- 2020-03-18 BR BR112021017198A patent/BR112021017198A2/pt unknown
- 2020-03-18 EP EP20716934.3A patent/EP3941473A1/en active Pending
- 2020-03-18 TW TW109109041A patent/TW202102221A/zh unknown
- 2020-03-18 KR KR1020217033037A patent/KR20210142004A/ko not_active Ceased
- 2020-03-18 AU AU2020243514A patent/AU2020243514A1/en not_active Abandoned
- 2020-03-18 CN CN202511459167.9A patent/CN121489955A/zh active Pending
- 2020-03-18 PH PH1/2021/551975A patent/PH12021551975A1/en unknown
- 2020-03-18 WO PCT/IB2020/052484 patent/WO2020188505A1/en not_active Ceased
- 2020-03-18 TW TW113116798A patent/TW202506129A/zh unknown
- 2020-03-18 KR KR1020267009764A patent/KR20260049872A/ko active Pending
- 2020-03-18 CA CA3129024A patent/CA3129024A1/en active Pending
- 2020-03-18 CN CN202080036713.7A patent/CN113840607A/zh active Pending
-
2021
- 2021-08-26 IL IL285910A patent/IL285910A/en unknown
-
2025
- 2025-02-07 JP JP2025018962A patent/JP2025084777A/ja active Pending
- 2025-10-23 AU AU2025256180A patent/AU2025256180A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2022524576A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| Tibblin et al. | Antihypertensive therapy with alprenolol, a β‐adrenergic receptor antagonist | |
| JP2013144704A (ja) | 流涎症の治療のためのアルファ−２受容体アゴニスト（クロニジン）と抗ムスカリン剤（オキシブチニン）との組み合わせ | |
| AU748993B2 (en) | Pharmaceutical combinations containing tramadol | |
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2024512425A5 (https=) | ||
| RU2009119258A (ru) | Способ лечения воспалительных заболеваний кишечника | |
| JP2020522560A5 (https=) | ||
| JP2020523334A5 (https=) | ||
| JP2022546456A5 (https=) | ||
| Frohlich et al. | Clinical trial of guanethidine, a new type of antihypertensive agent | |
| CN1543344A (zh) | 治疗尿失禁的芳基(或杂芳基)氮杂茂甲醇衍生物 | |
| JP2025060703A5 (https=) | ||
| JP2005511655A (ja) | 勃起障害の治療のためのアルカノイルｌ−カルニチンの使用 | |
| JP2021530568A5 (https=) | ||
| JP2024518804A5 (https=) | ||
| Reisin et al. | More rapid relief of pain with isosorbide dinitrate oral spray than with sublingual tablets in elderly patients with angina pectoris | |
| EP1553944B1 (fr) | Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l histamine | |
| JP2023060011A5 (https=) | ||
| WO2023165255A1 (zh) | 氨基金刚烷单硝酸酯类化合物在制药领域中的应用 | |
| JP2024507905A5 (https=) | ||
| JP2022521266A5 (https=) |